Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicin, 35 Shinano-cho, Shinjuku-ku, Tokyo, 160-0016, Japan.
Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicin, 35 Shinano-cho, Shinjuku-ku, Tokyo, 160-0016, Japan.
Respir Investig. 2024 Nov;62(6):1094-1101. doi: 10.1016/j.resinv.2024.09.009. Epub 2024 Sep 28.
Patients often experience multiple prolonged symptoms following acute coronavirus disease 2019 (COVID-19) recovery, defined as long coronavirus disease (COVID). Patients with long COVID may experience dyspnea during acute and post-acute phases. Therefore, this study aimed to identify specific risk factors for dyspnea in patients with long COVID.
Hospitalized patients with COVID-19, aged ≥18 years, were enrolled in this multicenter cohort study conducted at 26 medical institutions across Japan. Clinical data during hospitalization and patient-reported outcomes after discharge at the 3, 6, and 12-month follow-ups were retrieved from medical records and paper-based or smartphone application-based questionnaires, respectively.
Generalized linear mixed model (GLMM) analysis of prolonged dyspnea at each time point during follow-up showed that this symptom was associated with chronic obstructive pulmonary disease (COPD) (odds ratio [OR], 2.74; 95% confidence interval [CI], 1.31-5.74), asthma (OR, 2.21; 95%CI, 1.17-4.16), and ventilator management (OR, 3.10; 95%CI, 1.65-5.83). In addition, patients with COPD (44.4%) and ventilator management (25.0%) were more frequently associated with delayed dyspnea onset. The generalized estimating equations analysis results with multiple imputed datasets, conducted as a sensitivity analysis, confirmed the adjusted GLMM analysis results.
Prolonged dyspnea was associated with COPD, asthma, and severe infection that required mechanical ventilation in the Japanese population with long COVID. Further investigation is needed to clarify its mechanism and develop prophylactic and therapeutic strategies for dyspnea in patients with long COVID.
急性冠状病毒病 2019(COVID-19)康复后,患者常出现多种长期症状,即长冠病(COVID)。长 COVID 患者在急性和恢复期后可能会出现呼吸困难。因此,本研究旨在确定长 COVID 患者呼吸困难的特定危险因素。
这项多中心队列研究在日本 26 家医疗机构进行,纳入了年龄≥18 岁的 COVID-19 住院患者。从病历中检索了住院期间的临床数据,并从纸质或基于智能手机应用的问卷中检索了出院后 3、6 和 12 个月随访时的患者报告结局。
对随访期间每个时间点的持续性呼吸困难进行广义线性混合模型(GLMM)分析表明,这种症状与慢性阻塞性肺疾病(COPD)(比值比[OR],2.74;95%置信区间[CI],1.31-5.74)、哮喘(OR,2.21;95%CI,1.17-4.16)和呼吸机管理(OR,3.10;95%CI,1.65-5.83)有关。此外,患有 COPD(44.4%)和呼吸机管理(25.0%)的患者更常出现呼吸困难延迟发作。作为敏感性分析进行的具有多个插补数据集的广义估计方程分析结果证实了调整后的 GLMM 分析结果。
在日本长 COVID 人群中,持续性呼吸困难与 COPD、哮喘和需要机械通气的严重感染有关。需要进一步研究以阐明其机制,并为长 COVID 患者的呼吸困难制定预防和治疗策略。